johnson & johnson

"I Have Never Seen a Moment So Rich in Collaboration, Ingenuity and Acts of Bravery": Johnson & Johnson Announces It Has Identified a Lead Covid-19 Vaccine Candidate

Chairman & CEO Alex Gorsky shares that the company could have the first batches of a Covid-19 vaccine available for emergency-use authorization in early 2021—a substantially accelerated time frame in comparison to the typical vaccine development process.
Blog

By Alex Gorsky, Chairman & CEO, 

The Covid-19 pandemic is one of the greatest challenges to our society in living memory.

Yet even as we are heartbroken by the lives lost and the strain on our institutions and communities, countless people have been working tirelessly to offer the world a reason to feel pride, inspiration and hope.

Johnson & Johnson Announces a Lead Vaccine Candidate for COVID-19; Landmark New Partnership with U.S. Department of Health & Human Services; and Commitment to Supply One Billion Vaccines Worldwide for Emergency Pandemic Use

Summary: 
Johnson & Johnson and BARDA Together Commit More than $1 Billion to Novel Coronavirus Vaccine Research and Development; Company Expects to Initiate Phase 1 Human Clinical Studies of Vaccine Candidate at Latest by September 2020
Johnson & Johnson Will Establish New U.S. Vaccine Manufacturing Capabilities and Additional Production Capacity Outside the U.S. to Begin Production at Risk to Help Ensure Global Vaccine Supply
Press Release
Johnson & Johnson and BARDA Together Commit More than $1 Billion to Novel Coronavirus Vaccine Research and Development; Company Expects to Initiate Phase 1 Human Clinical Studies of Vaccine Candidate at Latest by September 2020
Johnson & Johnson Will Establish New U.S. Vaccine Manufacturing Capabilities and Additional Production Capacity Outside the U.S. to Begin Production at Risk to Help Ensure Global Vaccine Supply

What You Need to Know About How Johnson & Johnson's Supply Chain Is Responding to the Covid-19 Pandemic

The company's Chief Global Supply Chain Officer shares the measures the company has taken to maintain its supply chain operations during the current novel coronavirus outbreak.
Article

The effects of the global Covid-19 pandemic are undeniable.

As the world rapidly learns to adapt to an ever-changing landscape, Johnson & Johnson's supply chain, which produces everything from contact lenses to prescription medications to fever reducers, is currently holding steady and meeting patient needs.

Johnson & Johnson Announces Collaboration With the Beth Israel Deaconess Medical Center to Accelerate COVID-19 Vaccine Development

Press Release

NEW BRUNSWICK, N.J., March 13, 2020 /3BL Media/ – Johnson & Johnson today announced that its Janssen Pharmaceutical Companies have entered a collaboration with the Beth Israel Deaconess Medical Center (BIDMC) to support the development of a preventive vaccine candidate for COVID-19. The parties have commenced preclinical testing of multiple vaccine prospects, with the aim to identify by the end of the month a COVID-19 vaccine candidate for clinical trials.

Johnson & Johnson Goes All out to Fight Against Epidemic

Article

It was 9pm, January 22, one day before the Spring Festival holiday.

Wang Donghua, a Johnson & Johnson China employee in Wuhan, the epicenter of the COVID-19 outbreak, received a message from Will Song, chairman of Johnson & Johnson China. 

“Donghua, hope you and your family are well. We learnt the front-line hospitals urgently need protective gear, so the company decided to donate medical supplies to support the doctors and nurses. Can you please help facilitate the donation efforts as soon as possible? All the best.”

The X Factor: How Johnson & Johnson Has Helped Ignite the Power of Women Since 1886

Summary: 

For International Women's Day, we’re taking a look at some of the ways the company has shown its commitment to women—from industry-leading employee benefits to life-changing innovations.

Article

For International Women's Day, we’re taking a look at some of the ways the company has shown its commitment to women—from industry-leading employee benefits to life-changing innovations.

4 Questions for a Scientist Working on a Revolutionary CAR-T Therapy for Multiple Myeloma

By Jessica Brown
Article

The early data results seemed almost too good to be true.

That's what Sen Zhuang, M.D., Ph.D.,  Vice President, Oncology Clinical Research, Janssen Research & Development, was thinking at a meeting of the American Society of Clinical Oncology (ASCO) last summer.

An Expert Explains the Latest Good—Yes, Good!—News About Lung Cancer

By Jennifer Rainey Marquez
Summary: 

A new report from the American Cancer Society sheds light on declining death rates from cancer—especially lung cancer. We asked an expert on the disease to break down the data, and share what's to come in better detecting and preventing it.

Article

A new report from the American Cancer Society sheds light on declining death rates from cancer—especially lung cancer. We asked an expert on the disease to break down the data, and share what's to come in better detecting and preventing it.

Innovation Fueled by a Culture of Belonging and a Diverse Workforce at Johnson & Johnson

Multimedia with summary

For decades, Johnson & Jonson has been partnering with civic organizations to drive innovation that is fueled by a culture of belonging and a diverse workforce.

Today, Johnson & Jonson’s diversity & inclusion vision is for every person to use their unique experiences and backgrounds, together – to spark solutions that create a better, healthier world. Learn more: https://bit.ly/2SmYlWy

By the Numbers: 5 Ways Johnson & Johnson Is Helping Support Coronavirus Relief Efforts

From a donation of a million masks to help protect vulnerable healthcare workers to committed research on a potential vaccine, the company has activated quickly in several key ways to help address the outbreak.
Article

In times of need, every bit of help counts.

It's something Johnson & Johnson knows well: Throughout its over 130-year history, the company has had a legacy of coming to the aid of local and global communities during times of crisis, from natural disasters to health outbreaks.

Pages

Subscribe to johnson & johnson